The Bredesen Protocol™
Next Generation Protocol developed by the Inventors of MEND
The Protocol provides a comprehensive personalized program designed to improve cognition and reverse the cognitive decline of SCI, MCI, and early Alzheimer’s disease. Continued research and testing by Dr. Bredesen began by evolving MEND into The Bredesen Protocol™, which has identified new and previously unrecognized causes of Alzheimer’s disease.
Additional Information
Click on the items below for a brief introduction to the title subject and links to the complete reference.
Reversal of cognitive decline: A novel therapeutic program
Abstract Cognitive decline is a major concern of the aging population, and Alzheimer’s disease is the major cause of age-related cognitive...
Inhalational Alzheimer’s disease: An unrecognized—and treatable—epidemic
Abstract Alzheimer’s disease is now the third leading cause of death in the United States, following only cardiovascular disease and...
Metabolic profiling distinguishes three subtypes of Alzheimer’s disease
Abstract Alzheimer’s disease represents a major healthcare problem, with over five million Americans estimated to suffer from this...
Another Role for ApoE?
Abstract Key Alzheimer’s disease-related protein may be a transcriptional regulator. The allele apolipoprotein E c4 (APOE £4) is...
Direct Transcriptional Effects of Apolipoprotein E
Abstract A major unanswered question in biology and medicine is the mechanism by which the product of the apolipoprotein E ! 4 allele,...
Prionic Loops, Anti-Prions, and Dependence Receptors in Neurodegeneration
Abstract Stan had discovered and coined the term prions in 1982, and when I established my own laboratory in 1989, I wanted to address two...
Next generation therapeutics for Alzheimer’s disease
Abstract To date, no truly effective therapy has been developed for Alzheimer’s disease or mild cognitive impairment. In searching for new...
Reversal of Cognitive Decline in Alzheimer’s Disease
Abstract Alzheimer’s disease is one of the most significant healthcare problems nationally and globally. Recently, the first description...